top of page

Invest Early in the First Instant At-Home Testosterone Test—Capturing a Multi-Billion Dollar Men’s Health Market with Unparalleled Customer Loyalty.

Mission Statement

​

At MrMedTech, we believe the future of men’s health lies in the power of diagnostics—not as a barrier to care, but as the most effective engine for customer acquisition, loyalty, and lifetime value. When results are real, fast, affordable, and convenient, they don’t just inform treatment—they build trust, drive engagement, and unlock enduring clinical and commercial outcomes.

​

We’re starting with one of the most overlooked pain points in men’s healthcare: testosterone testing. Today, it's slow, expensive, and inconvenient—leading to delayed treatment, chronic symptoms, and billions in missed revenue across downstream care.

 

Our solution is the first truly instant, at-home testosterone test—delivering accurate results in minutes, with no lab visits, mail-in delays, or clinical friction. But the test itself is just the entry point.

 

This is more than a diagnostic breakthrough—it’s a scalable, high-conversion customer acquisition channel into what we believe will become the most efficient and profitable men’s health platform ever built.

 

From a single finger-prick test, we guide users into long-term care relationships across testosterone therapy, GLP-1-driven weight loss, ED treatment, hair loss medications, and other high-value, recurring prescriptions. Every touchpoint is vertically integrated—designed for maximum lifetime value and platform defensibility.

 

Our strategy is deliberate and scalable: Start with testing. Build trust through instant clarity. Convert into lifelong care.

​

At Mr. Med Tech, we believe the future of men’s health starts with diagnostics—not as a barrier to care, but as the gateway to long-term clinical and commercial outcomes.

Investment Opportunity

​

We are currently raising $3.5 million in Seed/Series A funding at a $25 million pre-money valuation.

Use of Funds:

  • Finalize FDA approval for our at-home testosterone test

  • Complete clinical validation and regulatory milestones

  • Launch our direct-to-consumer men’s health platform

  • Secure CLIA/CAP lab partnerships and pharmacy fulfillment

  • Execute targeted influencer and performance marketing campaigns

  • Grow team across R&D, regulatory, and operations

Investor Value Proposition:

  • First-mover advantage in instant at-home testosterone diagnostics

  • Recurring revenue via prescription memberships post-diagnosis

  • Licensing potential with leading telehealth platforms (e.g., Ro, Everlywell, Cue Health)

  • Exit optionality via acquisition or diagnostic licensing

Target Investor Profile

​

We are seeking strategic partners who understand the long-term value of diagnostic-driven care platforms. Ideal investors include:

​

  • Venture capital firms focused on digital health, diagnostics, and consumer healthcare

  • Health-tech angels and experienced operators in medtech, diagnostics, or DTC wellness

  • Corporate venture arms from pharma, lab testing, or men’s health platforms seeking licensing or M&A opportunities

Traction and Milestones

​

  • ✅ Prototype testosterone test developed, functioning, and feasibility test completed

  • ✅ Regulatory consultants identified; FDA 510(k) and CLIA roadmap complete

  • ✅ Strategic interest from men's health platforms for licensing or co-branding

  • ✅ Strategic interest from brick and mortar stores, online distribution partners, and clinics

  • 🔜 CLIA-waived finger-prick blood collection method finalized

  • 🔜 Influencer and celebrity marketing funnel build and launch

  • 🔜 Men's Telehealth app/platform build and launch

  • 🔜 Submission for FDA 510(k) clearance (target: Q4 2025)

  • 🔜 Product launch and user acquisition (target: Q4 2026)

Team Overview

​

  • Pritesh Patel – Co-Founder, & CTO

Medical Technologist AND Diagnostic systems expert with deep experience developing rapid tests and navigating lab regulatory standards. Built the proprietary testosterone test that anchors our platform.​

​

  • Brian Johnson – Co-Founder & CEO

Digital entrepreneur and eCommerce veteran with two decades of experience scaling digital-first platforms. Expert in influencer-driven marketing and direct-to-consumer health. Leads platform development, customer acquisition, and brand strategy.

Contact Us Now

​

If you're an investor who sees the power of diagnostics as the front door to scalable healthcare—let’s talk. We're building a platform that starts with our instant testosterone test and expands into a lifetime of care.

​

📩 Contact Brian directly or fill out the form below:
brian@mrmedtech.com
+1 (918) 732-5867

Thanks for submitting!

bottom of page